Bio Rad Laboratories Stock Alpha and Beta Analysis
| BIO Stock | USD 254.45 9.44 3.85% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bio Rad Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bio Rad over a specified time horizon. Remember, high Bio Rad's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bio Rad's market risk premium analysis include:
Beta 0.86 | Alpha (0.27) | Risk 2.37 | Sharpe Ratio (0.20) | Expected Return (0.47) |
Bio Rad Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bio |
Bio Rad Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bio Rad market risk premium is the additional return an investor will receive from holding Bio Rad long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio Rad. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bio Rad's performance over market.| α | -0.27 | β | 0.86 |
Bio Rad expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bio Rad's Buy-and-hold return. Our buy-and-hold chart shows how Bio Rad performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bio Rad Market Price Analysis
Market price analysis indicators help investors to evaluate how Bio Rad stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Rad shares will generate the highest return on investment. By understating and applying Bio Rad stock market price indicators, traders can identify Bio Rad position entry and exit signals to maximize returns.
Bio Rad Return and Market Media
The median price of Bio Rad for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 330.75 with a coefficient of variation of 11.36. The daily time series for the period is distributed with a sample standard deviation of 36.17, arithmetic mean of 318.42, and mean deviation of 30.79. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Is Adaptive Biotechnologies Stock Outpacing Its Medical Peers This Year | 01/17/2025 |
2 | Disposition of 279 shares by Andrew Last of Bio Rad at 4.6 subject to Rule 16b-3 | 01/23/2025 |
3 | Has BioRad Laboratories Outpaced Other Medical Stocks This Year | 02/04/2025 |
4 | Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO Investor Conference | 02/14/2025 |
5 | Bio Detectors and Accessories Market to Reach USD 52.9 Billion by 2032 SNS Insider | 02/21/2025 |
6 | Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinE... | 02/25/2025 |
7 | Bio-Rad International Revenue Performance Explored | 02/26/2025 |
8 | Principal Financial Group Inc. Divests 234 Shares of Bio-Rad Laboratories, Inc. | 02/27/2025 |
9 | High-Throughput Screening Technology Analysis and Global Markets 2021-2024 2025-2029 with Danaher, Thermo Fisher Scientific., Charles River Laboratories, Revvit... | 03/03/2025 |
10 | OncoCyte Corporation Among Penny Stocks with Insider Buying in 2025 | 03/04/2025 |
11 | Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50 percent CAGR - Credence Research | 03/06/2025 |
12 | Bio-Rad stock touches 52-week low at 248.05 amid market shifts - Investing.com India | 03/10/2025 |
13 | Neurological Biomarkers Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Bi... | 03/11/2025 |
About Bio Rad Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bio or other stocks. Alpha measures the amount that position in Bio Rad Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 64.43 | 66.82 | 76.84 | 87.31 | PTB Ratio | 1.3 | 1.08 | 1.41 | 2.13 |
Bio Rad Upcoming Company Events
As portrayed in its financial statements, the presentation of Bio Rad's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Rad's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bio Rad's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bio Rad. Please utilize our Beneish M Score to check the likelihood of Bio Rad's management manipulating its earnings.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Bio Rad
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Bio Rad Backtesting, Bio Rad Valuation, Bio Rad Correlation, Bio Rad Hype Analysis, Bio Rad Volatility, Bio Rad History and analyze Bio Rad Performance. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Bio Rad technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.